Whether developing new ways to detect cancer and cardiovascular disease, shortening the diagnostic journey for families affected by rare diseases or helping safeguard marine ecosystems while supporting responsible resource development, 10 University of Ottawa researchers are leading projects with the potential to deliver far-reaching benefits for Canada and the world.
As newly appointed or renewed Canada Research Chairs, these researchers are advancing discoveries that could transform patient care, strengthen health-care systems, inform environmental stewardship and expand the foundations of scientific knowledge. Their research reflects the breadth of expertise at uOttawa and the growing importance of interdisciplinary approaches in addressing complex global challenges.
Read the latest research funding announcement from the Government of Canada.
New research chairs
- Julie Côté, Faculty of Health Sciences
Canada Research Chair in Neuro-musculoskeletal Aspects of Movement - Dar Dowlatshahi, Faculty of Medicine and Ottawa Hospital Research Institute
Canada Research Chair in Stroke, Cardiovascular Disease and Targeted Interventions - John Jamieson, Faculty of Science
Canada Research Chair in Marine Geology - Laszlo Radvanyi, Faculty of Medicine and Ottawa Hospital Research Institute
Canada Research Chair in Translational Biotherapeutics - Martina Rovelli, Faculty of Science
Canada Research Chair in Higher Category Theory - Adam Shuhendler, Faculty of Science
Canada Research Chair in Multimodality Molecular Imaging - Kednapa Thavorn, Faculty of Medicine and Ottawa Hospital Research Institute
Canada Research Chair in Health Economics
Renewals
- Kym Boycott, Faculty of Medicine and CHEO Research Institute
Canada Research Chair in Rare Disease Precision Health - Arezu Jahani-Asl, Faculty of Medicine and Ottawa Hospital Research Institute
Canada Research Chair in Neurobiology of Disease - Deborah Siegal, Faculty of Medicine and Ottawa Hospital Research Institute
Canada Research Chair in Anticoagulant Treatment of Cardiovascular Disease
Additional investments in research
- A multidisciplinary team led by Dr. Bernard Thébaud of The Ottawa Hospital, CHEO and the University of Ottawa received a $24 million New Frontiers in Research Fund Transformation grant to accelerate the development of cell and gene therapies for chronic lung diseases.
- $1.29 million from the Canada Foundation for Innovation’s John R. Evans Leaders Fund to support research infrastructure.
- $13.7 million through the Research Support Fund (RSF) to support the institutional research environment.
- $5.1 million through RSF Incremental Project Grants to enhance research facilities, innovation and knowledge mobilization.
- $1.1 million in RSF Research Security funding to help safeguard Canada’s research enterprise.